Holdings of Goldman Sachs Future Health Care Equity ETF
Goldman Sachs ETF Trust · 39 declared positions · as of Feb 28, 2026
Original filing · Net assets 22.6M $ · Ten largest lines: 59.2 % of the equity sleeve
Sector breakdown
- Health care 55.7 %
- Unattributed 44.3 %
Titelia classification, company by company. The unattributed share stays visible.
Currency breakdown
- USD 85.3 %
- GBP 6.5 %
- JPY 3.7 %
- CHF 3.0 %
- EUR 1.6 %
The quoted currency of each line, as declared.
Country breakdown
- US 78.3 %
- GB 6.5 %
- JP 3.7 %
- NL 3.6 %
- CH 3.0 %
- BM 2.3 %
- FR 1.6 %
- CA 1.0 %
Shares computed on the equity sleeve.
| Country | Lines | Value | Share |
|---|---|---|---|
| US | 32 | 17.5M $ | 78.34 % |
| GB | 1 | 1.4M $ | 6.48 % |
| JP | 1 | 818.8K $ | 3.67 % |
| NL | 1 | 813.7K $ | 3.64 % |
| CH | 1 | 664.5K $ | 2.98 % |
| BM | 1 | 502.8K $ | 2.25 % |
| FR | 1 | 358.4K $ | 1.61 % |
| CA | 1 | 233.1K $ | 1.04 % |
Positions
| Company | Shares | Value | Weight |
|---|---|---|---|
| Eli Lilly & Co | 2,619 | 2.8M $ | 12.19 % |
| Johnson & Johnson | 7,357 | 1.8M $ | 8.09 % |
| AstraZeneca PLC | 6,923 | 1.4M $ | 6.40 % |
| Merck & Co Inc | 10,915 | 1.4M $ | 5.98 % |
| Boston Scientific Corp | 17,062 | 1.3M $ | 5.80 % |
| Thermo Fisher Scientific Inc | 2,001 | 1M $ | 4.61 % |
| Intuitive Surgical Inc | 2,003 | 1M $ | 4.46 % |
| Guardant Health Inc | 8,978 | 843K $ | 3.73 % |
| Hoya Corp | 4,523 | 818.8K $ | 3.62 % |
| Argenx SE | 1,061 | 813.7K $ | 3.60 % |
| Cencora Inc | 2,056 | 765.1K $ | 3.38 % |
| Abbott Laboratories | 6,078 | 707.2K $ | 3.13 % |
| Lonza Group AG | 953 | 664.5K $ | 2.94 % |
| Agilent Technologies Inc | 5,409 | 656.5K $ | 2.90 % |
| Dexcom Inc | 8,247 | 605.6K $ | 2.68 % |
| Roivant Sciences Ltd | 17,375 | 502.8K $ | 2.22 % |
| Mettler-Toledo International Inc | 293 | 400.4K $ | 1.77 % |
| Apogee Therapeutics Inc | 5,225 | 365.8K $ | 1.62 % |
| Sartorius Stedim Biotech | 1,658 | 358.4K $ | 1.59 % |
| Ionis Pharmaceuticals Inc | 3,918 | 317.9K $ | 1.41 % |
| QIAGEN NV | 6,309 | 314.2K $ | 1.39 % |
| Repligen Corp | 2,204 | 283.7K $ | 1.26 % |
| Insmed Inc | 1,846 | 275.7K $ | 1.22 % |
| Penumbra Inc | 750 | 258.3K $ | 1.14 % |
| Natera Inc | 1,137 | 236.5K $ | 1.05 % |
| Xenon Pharmaceuticals Inc | 5,393 | 233.1K $ | 1.03 % |
| Royalty Pharma PLC | 4,939 | 228.2K $ | 1.01 % |
| UnitedHealth Group Inc | 775 | 227.3K $ | 1.01 % |
| Cytokinetics Inc | 3,546 | 220.6K $ | 0.98 % |
| Bridgebio Pharma Inc | 3,115 | 207.1K $ | 0.92 % |
| Madrigal Pharmaceuticals Inc | 466 | 201.3K $ | 0.89 % |
| Rhythm Pharmaceuticals Inc | 2,150 | 199.4K $ | 0.88 % |
| CG oncology Inc | 3,187 | 187.4K $ | 0.83 % |
| Arcellx Inc | 1,623 | 184.7K $ | 0.82 % |
| GeneDx Holdings Corp | 1,664 | 132.6K $ | 0.59 % |
| Revolution Medicines Inc | 1,159 | 118.2K $ | 0.52 % |
| Insulet Corp | 432 | 106.5K $ | 0.47 % |
| Ultragenyx Pharmaceutical Inc | 3,619 | 84.6K $ | 0.37 % |
| Structure Therapeutics Inc | 1,092 | 68.8K $ | 0.30 % |